Morningstar

Icelandirect Acquires SOMA LABS, Significantly Expanding Dosage Form Manufacturing Capabilities for Human and Pet Supplement Brands

Icelandirect, LLC (“Icelandirect”), a portfolio company of New Heritage Capital, has acquired SOMA LABS, a New Jersey-based supplement manufacturer specializing in solid dosage form production. The ...
Business Wire

Enzian Pharmaceutics Develops a Novel Dosage Form for Enhanced Efficacy and Reduced Side Effects of Cancer Therapies

ZURICH & CAMBRIDGE, Mass.--(BUSINESS WIRE)--At present, the prevalent oral solid dosage forms, the capsules and tablets, are loose or lightly compacted mixtures of drug and excipient particles. Upon ...
JD Supra

FDA now recommends only one study to show bioequivalence for certain oral drug products - FDA also revises several hundred product specific guidances to align with ICH M13A BE ...

The U.S. Food and Drug Administration (FDA) issued final guidance on “M13A Bioequivalence for Immediate-Release Solid Oral Dosage Forms,” which provides advice on conducting bioequivalence (BE) ...
Yahoo Finance

Icelandirect Acquires SOMA LABS, Significantly Expanding Dosage Form Manufacturing Capabilities for Human and Pet Supplement Brands

CLIFTON, N.J., March 17, 2026--(BUSINESS WIRE)--Icelandirect, LLC ("Icelandirect"), a portfolio company of New Heritage Capital, has acquired SOMA LABS, a New Jersey-based supplement manufacturer ...